Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01398774 · ClinicalTrials.gov registry record

Energy Expenditure and Body Composition in Pseudohypoparathyroidism 1a

A clinical trial, sponsored by Children's Hospital of Philadelphia.

Terminated
Registry status
519
Enrollment target

NCT01398774: Clinical Trial study, sponsored by Children's Hospital of Philadelphia.

NCT01398774 is a clinical trial that was terminated before completion, run by Children's Hospital of Philadelphia. The registered enrollment target is 519 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01398774 was terminated before completion, sponsored by Children's Hospital of Philadelphia.

TERMINATED
Registry status
519 participants
Enrollment target

Study Summary

The investigators would like to learn more about the metabolic consequences of pseudohypoparathyroidism type 1a in children, adolescents and adults with this condition. People with pseudohypoparathyroidism 1a are at risk for development of obesity. To better understand the cause of overweight or obesity, investigators are measuring body composition and resting energy expenditure (REE), which is the amount of calories burned while completely at rest. The investigators also want to determine the amount of body fat.

Primary Outcome

The subject will rest for 30 minutes in the lab prior to the start of the test. A 60-minute resting energy expenditure (REE) test will be performed between 7:00 and 10:00 A.M. with the subject resting quietly under a clear, plastic hood watching a videotape.

Trial Details

FieldValue
Enrollment Target 519 participants
Start Date 2011-06
Est. Completion 2017-11-20
Children's Hospital of Philadelphia

431 total trials

Why NCT01398774 stopped before completion

NCT01398774 is an observational study that tracks outcomes without assigning an intervention. The registered 519 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01398774 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01398774 about?

NCT01398774 is a clinical study titled "Energy Expenditure and Body Composition in Pseudohypoparathyroidism 1a". The investigators would like to learn more about the metabolic consequences of pseudohypoparathyroidism type 1a in children, adolescents and adults with this condition. People with pseudohypoparathyroidism 1a are at risk for development of obesity. To better understand the cause of overweight or obe...

What is the current status of trial NCT01398774?

This trial is currently terminated. The enrollment target is 519 participants. The study started on 2011-06. Estimated completion is 2017-11-20.

Who is sponsoring clinical trial NCT01398774?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323581 · 520 participants · NA

    Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts

  • NCT04656496 · 520 participants · NA

    NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors

  • NCT05445778 · 520 participants · Phase 3

    Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

  • NCT05498428 · 520 participants · Phase 2

    A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01398774, the US trial registry maintained by the National Library of Medicine. NCT01398774 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.